The Global Pseudomonas Aeruginosa Treatment Market is projected to experience significant growth, reaching an estimated value of USD 11.2 billion by 2032, up from USD 5.6 billion in 2025. With a remarkable compound annual growth rate (CAGR) of 10.41%, the market is being driven by factors such as rising antimicrobial resistance and the increasing incidence of hospital-acquired infections. This...
English